Life Interrupted is a multifaceted experience developed in collaboration with Phil, an individual living with SCD, to give a front-row seat of what life is like for a person living with SCD and fully understand the lasting effects of this condition.
Reimagining Sickle Cell Disease
View and download a resource that discusses SCD-related priapism.
We’re taking a comprehensive approach to ensuring sickle cell disease (SCD) patients in sub-Saharan Africa, regardless of income, have access to our portfolio of medicines. Press play to learn more.

In SCD, vaso-occlusion and VOCs can lead to many complications.
SWAY was a multicountry, cross-sectional survey developed by international SCD experts, patient advocacy groups, and Novartis to assess the impact of SCD on the daily lives of patients.
VOC = vaso-occlusive crisis.
Reimagining Sickle Cell Disease
Compound(s) are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established and there is no guarantee that they will become commercially available for the use(s) under investigation.
MOA data are based on in vitro/in vivo data.

From utilizing CRISPR genome editing technology to collaborating on drug discovery with the Bill & Melinda Gates Foundation, Novartis continues to search for ways to improve the lives of sickle cell patients across the globe.




Explore Clinical Trials
Explore Clinical Trials


Adolescent & Adult
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism


Pediatric & Adolescent
Crizanlizumab in Pediatric and Adolescent Patients With Sickle Cell Disease and Vaso-occlusive Crisis
Explore Compounds
Explore Compounds


P-selectin–targeting monoclonal antibody
Compound(s) are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established and there is no guarantee that they will become commercially available for the use(s) under investigation.
MOA data are based on in vitro/in vivo data.
Learn about SCD companion, an app and how it can help you support your patients manage their sickle cell disease. Press play to View a brief introduction